IRLAB Therapeutics AB (publ) (FRA:6IRA)

Germany · Delayed Price · Currency is EUR

0.1812

+0.0016 (0.89%)

At close: Jan 9, 2026

Revenue by Product

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2019	2014 - 2018
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '19 Dec 31, 2019	2014 - 2018
Mesdopetam, Pirepemate and Integrative Screening Process	94.63M	Log In	Log In	Log In	Log In	Upgrade
Mesdopetam, Pirepemate and Integrative Screening Process Growth	1566.57%	Log In	Log In	Log In	Log In	Upgrade

Revenue by Geography

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2019	2014 - 2018
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '19 Dec 31, 2019	2014 - 2018
United States	94.63M	Log In	Log In	Log In	Log In	Upgrade
United States Growth	2142.37%	Log In	Log In	Log In	Log In	Upgrade
United Kingdom	-	Log In	Log In	Log In	Log In	Upgrade
United Kingdom Growth	-	Log In	Log In	Log In	Log In	Upgrade
Sweden	-	Log In	Log In	Log In	Log In	Upgrade
Sweden Growth	-	Log In	Log In	Log In	Log In	Upgrade